The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-N-[(1S)-1-(2-Cyclopropylethylcarbamoyl)-4-guanidino-butyl]-1-[(2S)-1-[(2S)-1-[4-[3-(3,4-dichlorophenyl)anilino]-4-oxo-butanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxamide ID: ALA5197024
Chembl Id: CHEMBL5197024
PubChem CID: 168286363
Max Phase: Preclinical
Molecular Formula: C42H55Cl2N9O6
Molecular Weight: 852.86
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CCC(=O)Nc1cccc(-c2ccc(Cl)c(Cl)c2)c1)C(=O)NCCC1CC1
Standard InChI: InChI=1S/C42H55Cl2N9O6/c43-30-15-14-28(25-31(30)44)27-6-1-7-29(24-27)49-36(54)16-17-37(55)51-21-4-10-34(51)40(58)53-23-5-11-35(53)41(59)52-22-3-9-33(52)39(57)50-32(8-2-19-48-42(45)46)38(56)47-20-18-26-12-13-26/h1,6-7,14-15,24-26,32-35H,2-5,8-13,16-23H2,(H,47,56)(H,49,54)(H,50,57)(H4,45,46,48)/t32-,33-,34-,35-/m0/s1
Standard InChI Key: JXOUXWWKTWFKCQ-BBACVFHCSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 852.86Molecular Weight (Monoisotopic): 851.3652AlogP: 4.02#Rotatable Bonds: 17Polar Surface Area: 210.13Molecular Species: BASEHBA: 7HBD: 6#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3CX Acidic pKa: 12.45CX Basic pKa: 11.85CX LogP: 1.89CX LogD: -0.20Aromatic Rings: 2Heavy Atoms: 59QED Weighted: 0.08Np Likeness Score: -0.82
References 1. Garsi JB, Komjáti B, Cullia G, Fejes I, Sipos M, Sipos Z, Fördős E, Markacz P, Balázs B, Lancelot N, Berger S, Raimbaud E, Brown D, Vuillard LM, Haberkorn L, Cukier C, Szlávik Z, Hanessian S.. (2022) Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics., 13 (6.0): [PMID:35707140 ] [10.1021/acsmedchemlett.2c00094 ]